American College of Clinical Pharmacy
      Search      Cart
         

PSAP in JACCP - Part I: Case Series: Perioperative Management of Patients in the ICU - 2024 June


Format to Purchase:
Member Price:
$14.95
Nonmember Price:
$14.95

Available for ACPE CREDIT ONLY

PSAP in JACCP features are developed from activities presented as part of the Pharmacotherapy Self-Assessment Program (PSAP).

Part I: Case Series: Perioperative Management of Patients in the ICU
This feature was developed from a chapter presented in PSAP 2023 Book 2 (Critical Care and Emergency Medicine).
  • Case Series: Click here to access the case series.



Release Date: June 08, 2024
BCPS Deadline: December 08, 2024
ACPE Deadline: June 08, 2027

Publication Year: 2024
Format: Online Test

Contents

Part I: Case Series: Perioperative Management of Patients in the ICU

Part I: Case Series: Perioperative Management of Patients in the ICU

Faculty

Melanie Smith Condeni, Pharm.D., BCCCP

Surgery Trauma Burn ICU Clinical Pharmacy Specialist

Reviewers

Molly Droege, Pharm.D., FCCP, BCPS

Clinical Pharmacy Specialist, Surgery, Orthopedics, and Trauma
UC Health - University of Cincinnati Medical Center

Asmaa K. Mohammed, Master of clinical pharmacy, SIDP, SIDP-AMS, BCPS

Senior Clinical Pharmacy Specialist
National liver institue

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience: Pharmacotherapy specialists and advanced level clinical pharmacists whose practice involves the direct care and management of critically ill patients in the ICU and emergency department.

Contents

Part I: Case Series: Perioperative Management of Patients in the ICU

Activity Number: 0217-0000-24-071-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based
Learning Objectives
  1. Design a pain management plan for a patient in the surgical ICU (SICU).
  2. Apply knowledge of shock types and markers of resuscitation to develop a postoperative resuscitation and hemodynamic management plan.
  3. Develop a plan for the prevention of common SICU complications.
  4. Develop a plan for the management of hematologic disorders of bleeding and prevention of thromboembolism for a SICU patient.
  5. Evaluate the anti-microbial regimen of a SICU patient for appropriateness with regard to site of infection, common pathogens, and duration of therapy.
  6. Justify appropriate blood glucose goals and convert a continuous insulin infusion for the management of stress hyperglycemia to an appropriate basal-bolus regimen in a SICU patient.

Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.